Do travelers really take their mefloquine malaria chemoprophylaxis? Estimation of adherence by an electronic pillbox

Journal of Travel Medicine

Volumn 13, Issue 1, 2006, Pages 8-14

  Landry, Pierre ^a,b   Iorillo, Danila ^a   Darioli, Roger ^a   Burnier, Michel ^a   Genton, Blaise ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MEFLOQUINE;

ADULT; ANXIETY; ARTICLE; CHEMOPROPHYLAXIS; DEPRESSION; DIZZINESS; DRUG MONITORING; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; NAUSEA; PATIENT COMPLIANCE; SIDE EFFECT; SLEEP DISORDER; TRAVEL; VOMITING;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; DRUG MONITORING; DRUG PACKAGING; ELECTRONICS; HUMANS; MALARIA; PATIENT COMPLIANCE; QUESTIONNAIRES; SWITZERLAND; TRAVEL;

EID: 33645313191     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2006.00005.x     Document Type: Article

References (30)

1. Phillips-Howard PA Radalewicz A Mitchell J Bradley DJ. Risk of malaria in British residents returning from malarious areas. BMJ 1990 300 499 503.
2. Muehlberger N Jelinek T Schlipkoeter U et al. Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya. Trop Med Int Health 1998 3 357 363.
3. Adera T Wolfe MS McGuire-Rugh K et al. Risk factors for malaria among expatriates living in Kampala, Uganda: the need for adherence to chemoprophylactic regimens. Am J Trop Med Hyg 1995 52 207 212.
4. D'Acremont V Landry P Müller I et al. Clinical and laboratory predictors of imported malaria: an aid to the medical decision making for returning travelers with fever. Am J Trop Med Hyg 2002 66 481 486.
5. Cobelens FGJ Leentvaar-Kuijpers A. Compliance with malaria chemoprophylaxis and preventative measures against mosquito bites among Dutch travellers. Trop Med Int Health 1997 2 705 713.
6. Reid AJC Whitty CJM Ayles HM et al. Malaria at Christmas: risks of prophylaxis versus risks of malaria. BMJ 1998 317 1506 1508.
7. Zastrow KD Dieckmann S Schöneberg I. Malariaeinschleppungen nach Deutschland 1989/1990. Zbl Hyg 1993 195 88 96.
8. Centers for Disease Control and Prevention (CDC). Malaria deaths following inappropriate malaria chemoprophylaxis - United States, 2001. MMWR Morb Mortal Wkly Rep 2001 50 597 599.
9. Kruse W. Patient compliance with drug treatment - new perspectives on an old problem. Clin Invest 1992 70 163 166.
10. Minodier P Nassur A Hassid S et al. Antimosquito precautions and medical chemoprophylaxis in French children with malaria. J Travel Med 2003 10 318 323.
11. Carme B Peguet C Nevez G. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa. Trop Med Int Health 1997 10 953 956.
12. Huzly D Schönfeld C Beuerle W Bienzle U. Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions. J Travel Med 1996 3 148 155.
13. Held TK Weinke T Mansmann U et al. Malaria prophylaxis: identifying risk groups for non-compliance. Q J Med 1994 87 17 22.
14. Phillips MA Kass RB. User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis. J Travel Med 1996 3 40 45.
15. Kollaritsch H Wiedermann G. Compliance of Austrian tourists with prophylactic measures. Eur J Epidemiol 1992 8 243 251.
16. Schlagenhauf P Steffen R Lobel H et al. Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health 1996 4 485 494.
17. Lobel HO Phillips-Howard PA Brandling-Bennett AD et al. Malaria incidence and prevention among European and North American travellers to Kenya. Bull World Health Organ 1990 68 209 215.
18. Lobel HO Campbell CC Papaioanou M Huong AY. Use of prophylaxis for malaria by American travelers to Africa and Haiti. JAMA 1987 257 2626 2627.
19. Lobel H Baker MA Graz FA et al. Use of malaria prevention measures by North American and European travelers to East Africa. J Travel Med 2001 8 167 172.
20. Laver SM Wetzels J Behrens RH. Knowledge of malaria, risk perception and compliance with chemoprophylaxis and personal and environmental preventive measures in travelers exiting Zimbabwe from Harare and Victoria Fall International Airport. J Travel Med 2001 8 298 303.
21. Behrens RH Taylor RB Pryce DI Low AS. Chemoprophylaxis compliance in travelers with malaria. J Travel Med 1998 5 92 94.
22. Urquart J. The electronic medication event monitor. Clin Pharmacokinet 1997 32 345 356.
23. Cramer JA Mattson RH Prevey ML et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989 261 3273 3277.
24. Burnier M Santschi V Favrat B Brunner HR. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens 2003 21 Suppl 2 S37 S42.
25. Burnier M Schneider MP Chiolero A et al. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001 19 335 341.
26. Schwed A Fallab CL Burnier M et al. Electronic monitoring of compliance to lipid-lowering therapy in clinical practice. J Clin Pharmacol 1999 39 402 409.
27. Claxton A de Klerk E Parry M et al. Patient compliance to new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder. J Clin Psychiatry 2000 61 928 932.
28. Mimica I Fry W Eckert G et al. Multiple dose kinetic study of mefloquine in healthy male volunteers. Chemotherapy 1983 29 184 187.
29. Hellgren U Angel VH Bergqvist Y et al. Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis. Trans R Soc Trop Med Hyg 1990 84 46 49.
30. Rombo L Angel VH Friman G et al. Comparative tolerability and kinetics during long-term intake of lariam an fansidar for malaria prophylaxis in nonimmune volunteers. Trop Med Parasitol 1993 44 254 256.